Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11

Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 — Rankings · CancerIndex

Rankings

Why this rank?

3 current ranking rows (latest year per scope). Each row lists the scope, the formula version, the value and the exact inputs that produced it.

Metric	Scope	Rank / eligible	Δ	Value	Percentile	Confidence	Formula	Generated	Inputs
Active clinical trials	World · both sexes · all ages · latest · all malignant entities	#795 / 1,654	=	4 count	52	Medium confidence	ci-active-trials-v1	Sep 29, 2026	show formula: COUNT(DISTINCT trial) FROM trial_conditions JOIN clinical_trials WHERE cancer_id IN descendants(cancer) AND study_type = INTERVENTIONAL AND overall_status IN (RECRUITING, NOT_YET_RECRUITING, ENROLLING_BY_INVITATION, ACTIVE_NOT_RECRUITING) counter activeTrialCount computedAt 2026-09-29T06:00:20.557Z inputs hash f2f5ed2084d93bba6dcb810e Trace lineage (admin)
Recruiting clinical trials	World · both sexes · all ages · latest · all malignant entities	#743 / 1,277	=	2 count	41.8	Medium confidence	ci-recruiting-trials-v1	Sep 29, 2026	show formula: COUNT(DISTINCT trial) … overall_status = RECRUITING AND study_type = INTERVENTIONAL counter recruitingTrialCount computedAt 2026-09-29T06:00:20.557Z inputs hash 4352f89d0670b61272a585b3 Trace lineage (admin)
Trial termination share	World · both sexes · all ages · latest · all malignant entities	#333 / 454	=	0.31 ratio	26.7	Medium confidence	ci-trial-termination-v1	Sep 29, 2026	show formula: (terminated + withdrawn) / (completed + terminated + withdrawn) WHERE first_posted_date ≥ 2010-01-01 AND study_type = INTERVENTIONAL asOf 2026-09-29 since 2010-01-01 terminal 72 completed 50 studyType INTERVENTIONAL withdrawn 4 terminated 18 aggregation descendants activeStatuses RECRUITING NOT_YET_RECRUITING ENROLLING_BY_INVITATION ACTIVE_NOT_RECRUITING

Computed Ranks are competition ranks (ties share a rank). Percentile = share of eligible entities ranked at or below this one in the ranking direction.

"Deadliest" is ambiguous: annual deaths, age-standardized mortality rate, mortality-to-incidence ratio and 5-year survival rank cancers differently. CancerIndex publishes each as a separate metric.

Why this rank?

Research gap